PharmaDirections President Richard Soltero to Discuss Issues and Case Studies of Virtual CROs
Dr. Richard Soltero, president of PharmaDirections, Inc. PharmaDirections.com, will address the Pharmaceutical Outsourcing Management Association’s (POMA) 10th Annual Meeting Feb. 8-10, 2005, at the Hyatt Regency La Jolla at Aventine in San Diego. Dr. Soltero will present “Pre-Clinical Outsourcing Issues and Case Studies” as part of the annual event.
Raleigh, NC (PRWEB) January 27, 2005 -- Dr. Richard Soltero, president of
PharmaDirections, Inc. www.PharmaDirections.com, will address the Pharmaceutical
Outsourcing Management Association’s (POMA) 10th Annual Meeting Feb. 8-10, 2005,
at the Hyatt Regency La Jolla at Aventine in San Diego. Dr. Soltero will present
“Pre-Clinical Outsourcing Issues and Case Studies” as part of the annual
event.
Dr. Soltero is scheduled to speak on Wednesday, Feb. 9, and will
discuss how the concept of virtual contract research organizations (CROs) can
add significant value to biotechnology and small pharmaceutical companies by
reducing their development timelines, making best use of working capital,
increasing valuation, and accelerating investor return. In addition, he will
present skills and tactics essential to working effectively with traditional
CROs and managing their costs.
“This is a chance for PharmaDirections to
present new techniques and tactics for working with CROs,” said Dr. Soltero. “I
will show how a virtual CRO model saves time and money for clients who are
engaged in drug development activities.”
Dr. Soltero said
PharmaDirections offers a virtual CRO model that allows clients to access top
scientists in specialty areas that are geographically dispersed across the
globe. This team can use existing manufacturing facilities for clinical trial
material production without the overhead cost of maintaining and staffing these
facilities full time. He said this model provides biotech and pharmaceutical
companies with the ability to successfully develop drug candidates with minimal
capital investment and without the heavy investment of labs, personnel and fixed
expenses.
The POMA Annual Meeting is entitled “Trends in
Biopharmaceutical Outsourcing: Clinical and Manufacturing Outsourcing in
Pharmaceutical and Biotech Companies” and will be presented in an interactive
format, allowing open dialogue among presenters and attendees.
About
PharmaDirections, Inc.
PharmaDirections is a leading pharmaceutical
development consulting company in North America, with headquarters in Research
Triangle Park, North Carolina. PharmaDirections is a drug product development
consultation firm serving clients either as independent consultants or as part
of an integrated team. They leverage the development and outsourcing expertise
of 65+ associates on their staff to help accelerate client compounds through the
drug development process in a more cost effective manner. For more information,
please visit www.PharmaDirections.com, or call 919-657-0660.
About
POMA
The Pharmaceutical Outsourcing Management Association was established in
1995 as a forum to exchange ideas and experiences about outsourcing in the
pharmaceutical industry. POMA was created to improve the collective knowledge
and understanding of the rapidly evolving environment of contract drug
development and manufacturing. For more information, please visit www.pomasite.com.
# #
#
Source : http://www.prweb.com/releases/2005/1/prweb201431.htm